IGF2BP3 enhances paclitaxel resistance in bladder urothelial carcinoma by recognizing m(6)A-modified CENPA mRNA. Yi H, Han Y, Wang X, Li Q, et al. Med Oncol 2026;43:278.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yi H, Han Y, Wang X, Li Q, et al. IGF2BP3 enhances paclitaxel resistance in bladder urothelial carcinoma by recognizing m(6)A-modified CENPA mRNA. Med Oncol 2026;43:278.
PMID: 42720822